Zhenoluten N60 – ovarian peptides (A-15)

Peptide complex Jenoluten actively influences the regulation of female reproductive performance through targeted and selective impact of ovarian peptides isolated from the organ tissues of young calves (up to 11 months).

Peptides are one of the important components of the complete nutrition of ovarian cells, as well as affecting the process of protein synthesis and gene expression.

Ovarian peptides are produced at an early age, but as the human body grows older and stresses increase, protein synthesis activity decreases and ovarian cell function is impaired as a result of peptide deficiency.

Today it is possible to counteract the deficiency of ovarian peptides by taking the drug Genoluten, based on peptides of mammalian ovarian tissue, thereby replenishing the pool of regulatory peptides that are produced by the ovaries.

The main actions of Jenoluten

– optimizing ovarian function;

– reducing ovarian atrophy;

– reducing the risk of pathologies in the ovaries.

Genoluten is recommended for:

disorders of the ovaries;
menstrual cycle disruptions;
endometriosis;
women’s infertility;
climacteric disorders;
hormone-dependent reproductive system diseases;
decreased libido.
The preparation Genoluten proved to be excellent for optimization of functioning of the genital system in elderly women, and no side effects were revealed. Genoluten is recommended for the treatment of age-related ovarian diseases in combination with other medicines.

Admission rules

The average course of Genoluten is 1-2 months, after which one should take a 1-3 month break and repeat the course of treatment.

One capsule of Genoluten contains 3.6% ovarian extract and excipients

Product composition
Microcrystalline cellulose (E460); beet sugar; lactose; starch; peptide complex A-15 (ovarian peptides); tween-80.

A daily dose contains: (2 capsules), 20 mg of peptide complex A-15.

How to use
Adults: 1-2 capsules 1-2 times daily with meals. Duration of use – 1 month.

Form: 60 capsules of 0.2 g